SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (91)1/23/2001 12:34:27 PM
From: tuck  Read Replies (1) | Respond to of 469
 
Thanks, nigel,

If GenomeWeb.com is the bomb, you're the Nuke (that's meant to be a compliment). I see a couple of factors in addition to OGSI's solidity for buying here. The strong possibility of further Fed cuts making the Euro look more attractive in the intermediate term, and this indiscriminate dumping (note my last post on Trickle, mentioning the aversion for development stage genomics companies/IPO's in the U.S. right now) . . . I think I might take a contrarian nibble here.

Cheers, Tuck



To: nigel bates who wrote (91)1/23/2001 12:48:17 PM
From: tuck  Respond to of 469
 
Gee, I should have played harder ball with those desperados. With the B/A at 17 5/8 to 18 5/16, I put in an order for 18 1/8 for 100 shares. Filled instantly.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News